Takeda closes South San Francisco R&D site in California restructuring
This article was originally published in Scrip
Executive Summary
Takeda has decided to close a US research site in South San Francisco that was specialising in the discovery of antibody therapeutics, "relocating the most essential antibody and biologics research technologies and staff" to another existing facility in San Diego.